ROMAGNOLI, Romeo
 Distribuzione geografica
Continente #
NA - Nord America 23.389
AS - Asia 10.306
EU - Europa 7.056
SA - Sud America 1.744
AF - Africa 165
Continente sconosciuto - Info sul continente non disponibili 15
OC - Oceania 10
Totale 42.685
Nazione #
US - Stati Uniti d'America 23.007
SG - Singapore 4.036
CN - Cina 3.218
DE - Germania 2.099
BR - Brasile 1.492
UA - Ucraina 1.300
HK - Hong Kong 991
TR - Turchia 912
GB - Regno Unito 781
IT - Italia 663
RU - Federazione Russa 553
VN - Vietnam 533
SE - Svezia 490
FI - Finlandia 423
FR - Francia 220
MX - Messico 183
PL - Polonia 172
CA - Canada 167
IN - India 135
AR - Argentina 98
ID - Indonesia 84
ZA - Sudafrica 79
BD - Bangladesh 77
ES - Italia 71
JP - Giappone 69
BE - Belgio 67
NL - Olanda 60
IQ - Iraq 42
EC - Ecuador 35
AT - Austria 34
LT - Lituania 34
CO - Colombia 33
VE - Venezuela 28
PK - Pakistan 27
EG - Egitto 24
KR - Corea 24
UZ - Uzbekistan 23
CZ - Repubblica Ceca 22
MA - Marocco 20
AE - Emirati Arabi Uniti 18
PY - Paraguay 17
CL - Cile 16
SA - Arabia Saudita 16
TN - Tunisia 13
IL - Israele 12
NP - Nepal 12
KE - Kenya 11
UY - Uruguay 11
EU - Europa 10
AU - Australia 9
TT - Trinidad e Tobago 9
AZ - Azerbaigian 8
IR - Iran 8
PT - Portogallo 8
AL - Albania 7
BG - Bulgaria 7
JO - Giordania 7
LV - Lettonia 7
PE - Perù 7
DZ - Algeria 6
KG - Kirghizistan 6
KZ - Kazakistan 6
OM - Oman 6
TH - Thailandia 6
BO - Bolivia 5
IE - Irlanda 5
CH - Svizzera 4
DO - Repubblica Dominicana 4
HN - Honduras 4
HR - Croazia 4
PS - Palestinian Territory 4
RO - Romania 4
A2 - ???statistics.table.value.countryCode.A2??? 3
ET - Etiopia 3
GA - Gabon 3
GR - Grecia 3
LB - Libano 3
MK - Macedonia 3
PH - Filippine 3
AO - Angola 2
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
BY - Bielorussia 2
GE - Georgia 2
GP - Guadalupe 2
MD - Moldavia 2
MN - Mongolia 2
MY - Malesia 2
NI - Nicaragua 2
PA - Panama 2
QA - Qatar 2
RS - Serbia 2
SN - Senegal 2
SY - Repubblica araba siriana 2
TW - Taiwan 2
XK - ???statistics.table.value.countryCode.XK??? 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
BB - Barbados 1
BN - Brunei Darussalam 1
Totale 42.662
Città #
Fairfield 2.520
Woodbridge 2.398
Singapore 2.376
Ashburn 2.220
Houston 1.564
Jacksonville 1.385
Chandler 1.308
Ann Arbor 1.234
Dallas 1.090
Beijing 995
Hong Kong 982
Santa Clara 952
Seattle 910
Wilmington 845
Cambridge 762
Izmir 469
Nanjing 434
Princeton 313
Los Angeles 305
Boardman 253
Ferrara 240
Munich 233
San Diego 227
New York 207
Ho Chi Minh City 168
Shanghai 160
Warsaw 153
Shenyang 146
São Paulo 140
Milan 132
Hefei 125
Nanchang 121
Mexico City 120
Bremen 101
London 100
Tianjin 100
Hanoi 92
Changsha 87
Falkenstein 87
Hebei 85
Brooklyn 84
San Mateo 80
Jiaxing 77
Helsinki 76
Turku 75
Orem 73
Chicago 70
Brussels 66
Dong Ket 62
Montreal 61
Tokyo 61
Jakarta 57
Moscow 56
Rio de Janeiro 54
Atlanta 53
The Dalles 53
Frankfurt am Main 52
Jinan 51
Philadelphia 50
Norwalk 48
Toronto 48
Zhengzhou 46
Johannesburg 45
Kunming 45
Phoenix 45
Denver 44
Falls Church 44
Dearborn 43
Stockholm 43
Addison 42
Mountain View 42
Chennai 40
Boston 39
Redwood City 35
Guangzhou 34
Manchester 34
San Francisco 34
Orange 33
Brasília 32
Amsterdam 31
Council Bluffs 30
Poplar 30
Buffalo 29
Paris 29
Washington 28
Belo Horizonte 27
Des Moines 27
Indiana 27
Asnières-sur-Seine 26
Ankara 24
Ningbo 24
Auburn Hills 23
Curitiba 23
Nuremberg 23
Columbus 22
San Jose 22
Taizhou 22
Haiphong 21
Mumbai 20
Tappahannock 20
Totale 28.694
Nome #
1,3-Dipropyl-8-(1-phenylacetamide-1H-pyrazol-3-yl)-xanthine derivatives as highly potent and selective human A2B adenosine receptor antagonists 1.174
[2,1-c][1,4]benzodiazepine (PBD)-distamycin hybrid inhibits DNA binding to transcription factor Sp1 488
A chemoenzymatic approach to chiral phenylisoserinates using 4-isopropyl-2-oxazolin-5-one as masked umpoled synthon for hydroxycarbonyl anion 263
1-methyl-3-nitro-5-methoxycarbonyl pyrazole 261
2-Alkoxycarbonyl-3-arylamino-5-substituted thiophenes as a novel class of antimicrotubule agents: Design, synthesis, cell growth and tubulin polymerization inhibition 241
A3 Adenosine Receptors as Modulators of Inflammation: From Medicinal Chemistry to Therapy 240
A3 adenosine receptor antagonists: History and future perspectives 235
Design, synthesis, and biological evaluation of novel 2-((2-(4-(substituted)phenylpiperazin-1-yl)ethyl)amino)-5'-N-ethylcarboxamidoadenosines as potent and selective agonists of the A2A adenosine receptor 234
A synthetic approach for the preparation of rigid analogs of 1,3-dipropyl-7-methyl-8-aryl/heteroarylstyryl xanthines 233
Inhibition of activated STAT5 in Bcr/Abl expressing leukemia cells with new pimozide derivatives. 232
Positive allosteric modulation of A1 adenosine receptors as a novel and promising therapeutic strategy for anxiety 231
A one-pot synthesis of nitrohydroxylated pyrrolidine and piperidine ring systems by tandem Michael-Henry reaction 230
Effects of Pimozide Derivatives on pSTAT5 in K562 Cells 228
7-Substituted-pyrrolo[3,2-d]pyrimidine-2,4-dione derivatives as antagonists of the transient receptor potential ankyrin 1 (TRPA1) channel: A promising approach for treating pain and inflammation 227
Design, synthesis and biological evaluation of 3-substituted-2-oxindole hybrid derivatives as novel anticancer agents 227
A convenient synthesis of unsymmetrically substituted terphenyls of biologically active stilbenes via a double Suzuki cross-coupling protocol 226
Design and Synthesis of Potent in Vitro and in Vivo Anticancer Agents Based on 1-(3’,4’,5’-Trimethoxyphenyl)-2-Aryl-1H-Imidazole 223
Hydropathic analysis and biological evaluation of stilbene derivatives as colchicine site microtubule inhibitors with anti-leukemic activity 220
Allosteric modulators for the A1-adenosine receptor 219
Design, synthesis, DNA binding, and biological evaluation of water-soluble hybrid molecules containing two pyrazole analogues of the alkylating cyclopropylpyrroloindole (CPI) subunit of the antitumor agent CC-1065 and polypyrrole minor groove binders 216
New heterocyclic ligands for the adenosine receptors P1 and for the ATP receptors P2. 215
7-Oxo-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxamides as Selective CB2 Cannabinoid Receptor Ligands: Structural Investigations around a Novel Class of Full Agonists 215
Design, synthesis and in vitro cytotoxicity of a cis-dichloroplatinum(II) complex linked to the minor groove binder stallimycin 212
DNA minor groove binders as potential antitumor and antimicrobial agents 211
Synthesis and Biological Evaluation of 2-Methyl-4,5-Disubstituted Oxazoles as a Novel Class of Highly Potent Antitubulin Agents 210
Synthesis and biological effects of a new series of 2-amino-3-benzoylthiophenes as allosteric enhancers of A1-adenosine receptor 209
New 2-heterocyclyl-imidazo[2,1- i ]purin-5-one derivatives as potent and selective human A 3 adenosine receptor antagonists 209
Enantioselective synthesis of (-)-meroquinene through tandem Michael reaction methodology 208
Allosteric enhancers for A(1) adenosine receptor 207
N-6-[(Hetero)aryl/(cyclo)alkyl-carbamoyi-methoxy-phenyl]-(2chloro)-5 '-N-ethylearboxamido-adenosines: The first example of adenosine-related structures with potent agonist activity at the human A(2B) adenosine receptor 206
Design, synthesis, in vitro, and in vivo anticancer and antiangiogenic activity of novel 3-arylaminobenzofuran derivatives targeting the colchicine site on tubulin 206
1H-pyrazolo[2,3-d][1,2,4]triazine-3,7-diones as a new class of human leukocyte elastase inhibitors 203
Pyrazole phenylcyclohexylcarbamates as inhibitors of human fatty acid amide hydrolases (FAAH) 201
Synthesis and biological evaluation of 2-and 3-aminobenzo[b]thiophene derivatives as antimitotic agents and inhibitors of tubulin polymerization 199
Heterocyclic and phenyl double-bond-locked combretastatin analogues possessing potent apoptosis-inducing activity in HL60 and in MDR cell lines 199
2-Arylamino-4-amino-5-aroylthiazoles. "One-pot" synthesis and biological evaluation of a new class of inhibitors of tubulin polymerization 199
Binding of hybrid molecules containing pyrrolo [2,1-c][1,4]benzodiazepine (PBD) and oligopyrrole carriers to the human immunodeficiency type 1 virus TAR-RNA 198
[H-3]-MRE 2029-F20, a selective antagonist radioligand for the human A(2B) adenosine receptors 198
Novel A-ring and B-ring modified combretastatin A-4 (CA-4) analogues endowed with interesting cytotoxic activity 198
Novel 8-heterocyclyl xanthine derivatives in drug development - An update 197
Pyrazolo [4,3-e][1,2,4]triazolo[1,5-c]pyrimidine template: Organic and medicinal chemistry approach 196
Synthesis and preliminary biological evaluation of new anti-tubulin agents containing different benzoheterocycles 196
Novel iodoacetamido benzoheterocyclic derivatives with potent antileukemic activity are inhibitors of STAT5 phosphorylation 195
Hybrid molecules between distamycin A and active moieties of antitumor agents 194
Mastering β-Keto Esters 193
From tyrosine to glycine: Synthesis and biological activity of potent antagonists of the purinergic P2X(7) receptor 192
One-pot reaction to obtain N,N'-disubstituted guanidines of pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidine scaffold as human A3 adenosine receptor antagonists 192
Hybrid molecules based on distamycin A as potential antitumor agents 192
New heterocyclic ligands for the adenosine receptors P1 and for the ATP receptors P2 191
Discovery and Optimization of a Series of 2-Aryl-4-Amino-5-(3 ',4 ',5 '-trimethoxybenzoyl)Thiazoles as Novel Anticancer Agents 191
Synthesis, in vitro antiproliferative activity, and DNA-binding properties of hybrid molecules containing pyrrolo[2,1-c][1,4] benzodiazepine and minor-groove-binding oligopyrrole carriers 191
Asymmetrical nitrido tc-99m heterocomplexes as potential imaging agents for benzodiazepine receptors 189
Current status of A1 adenosine receptor allosteric enhancers 189
Bis-epoxyethyl derivatives of distamycin A modified on the amidino moiety: Induction of production of fetal hemoglobin in human erythroid precursor cells 189
Synthesis and biological evaluation of 2-(3 ',4 ',5 '-trimethoxybenzoyl)-3-amino 5-aryl thiophenes as a new class of tubulin inhibitors 188
Design, synthesis and antiproliferative activity of novel heterobivalent hybrids based on imidazo[2,1-b][1,3,4]thiadiazole and imidazo[2,1-b][1,3]thiazole scaffolds 188
Water-Soluble Pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidines as Human A3 Adenosine Receptor Antagonists 187
Structure-activity relationship studies of a new series of imidazo[2,1-f] purinones as potent and selective A3 adenosine receptor antagonists 186
Pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidines and linked Heterocycles as template for the adenosine receptor antagonism: Medicinal chemistry approach and sar considerations 185
A mild one-pot synthesis of thieno[3,4-c]pyrazoles and their conversion into pyrazole analogs of o-quinodimethane 184
Synthesis of hybrid distamycin-cysteine labeled with 99mTc: a model for a novel class of cancer imaging agents 184
Design, synthesis, in vitro antiproliferative activity and apoptosis-inducing studies of 1-(3',4',5'-trimethoxyphenyl)-3-(2'-alkoxycarbonylindolyl)-2-propen-1-one derivatives obtained by a molecular hybridisation approach 183
Design, synthesis and growth inhibition activity of bis-epoxyethyl derivatives of stallimycin modified on the amidino moiety 182
Cinnamoyl nitrogen mustard derivatives of pyrazole analogues of tallimustine modified at the amidino moiety: design, synthesis, molecular modeling and antitumor activity studies 182
A new synthetic approach to indazole synthesis 182
A new synthetic approach to pyrazolo[3,4-c]-1,2,5-oxadiazoles 182
[H-3]MRE 3008F20: A novel antagonist radioligand for the pharmacological and biochemical characterization of human A(3) adenosine receptors 181
Synthesis of a new series of pyrazolo[1,5-a]pyrimidines structurally related to zaleplon 180
Design, synthesis, and biological evaluation of new 8-heterocyclic xanthine derivatives as highly potent and selective human A(2B) adenosine receptor antagonists 180
Synthesis and Biological Evaluation of Novel Allosteric Enhancers of the A1 Adenosine Receptor Based on 2-Amino-3-(4’-Chlorobenzoyl)-4-Substituted-5-Arylethynyl Thiophene 180
2-aminothiophene-3-carboxylic acid ester derivatives as novel highly selective cytostatic agents 180
Synthesis of conformationally constrained analogues of KN62, a potent antagonist of the P2X7-receptor 177
7-substituted-5-amino-2-(furyl)-pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidines as A2A adenosine receptor antagonists: importance of modifications at the side chain on the activity and solubility. 177
Synthesis and biological evaluation of 2-amino-3-(4-chlorobenzoyl)-4-[N- (substituted) piperazin-1-yl]thiophenes as potent allosteric enhancers of the A1 adenosine receptor 177
Microwave-assisted synthesis of thieno[2,3-c]pyridine derivatives as a new series of allosteric enhancers at the adenosine A(1) receptor 177
Synthesis and biological evaluation of 2-amino-3-(3',4',5'-trimethoxyphenylsulfonyl)-5-aryl thiophenes as a new class of antitubulin agents 176
7-substituted 5-amino-2-(2-furyl)pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines as A(2A) adenosine receptor antagonists: A study on the importance of modifications at the side chain on the activity and solubility 176
Biological effects of novel 2-amino-3-naphthoylthiophenes as allosteric enhancers of the A1 adenosine receptors 175
Structure-activity relationships around the KN-62, a potent antagonist of the P2X(7)receptor 173
Novel combretastatin analogues endowed with antitumor activity 173
Synthesis and biological evaluation of 2-amino-3-(4-chlorobenzoyl)-4-[(4- arylpiperazin-1-yl)methyl]-5-substituted-thiophenes. Effect of the 5-modification on allosteric enhancer activity at the A1 adenosine receptor 172
Synthesis and Biological Evaluation of 1-Methyl-2-(3’,4’,5’-Trimethoxybenzoyl)-3-Amino Indoles as a New Class of Antimitotic Agents and Tubulin Inhibitors 171
Recent developments in the field of adenosine receptor ligands. 169
Recent improvements in the development of A2B adenosine receptor agonists 168
Microwave-assisted synthesis of substituted 2,4-diarylthiazoles and their evaluation as anticancer agents 166
A Facile Synthesis of Diaryl Pyrroles Led to the Discovery of Potent Colchicine Site Antimitotic Agents 166
Allosteric Modulators of the A1 Adenosine receptor 165
New potent and selective human adenosine A3 receptor antagonists. 165
Hybrid molecules containing benzo[4,5]imidazo[1,2-d][1,2,4]thiadiazole and alpha-bromoacryloyl moieties as potent apoptosis inducers on human myeloid leukaemia cells 163
New 2-arylpyrazolo[4,3-c]quinoline derivatives as potent and selective human A(3) adenosine receptor antagonists 162
Resolution of a CPzI precursor, synthesis and biological evaluation of (+) and (-)-N-Boc-CPzI: A further validation of the relationship between chemical solvolytic stability and cytotoxicity 162
New pyrrolo[2,1-f]purine-2,4-dione and imidazo[2,1-f]purine-2,4-dione derivatives as potent and selective human A(3) adenosine receptor antagonists 160
Recent improvements in the development of A2B adenosine receptor agonists 160
Synthesis and antitumor activity of novel distamycin derivatives 159
Total synthesis of (+/-)-epibatidine 159
Design, Synthesis, and Biological Evaluation of 6-Substituted Thieno[3,2-d]pyrimidine Analogues as Dual Epidermal Growth Factor Receptor Kinase and Microtubule Inhibitors 159
Recent developments in the field of A(2A) and A(3) adenosine receptor antagonists 158
Synthesis, Antimitotic and Antivascular Activity of 1-(3’,4’,5’-Trimethoxybenzoyl)-3-Arylamino-5-Amino-1,2,4-Triazoles 158
Benzoyl and cinnamoyl nitrogen mustard derivatives of benzoheterocyclic analogues of the tallimustine: Synthesis and antitumour activity 157
Synthesis, radiolabeling, and preliminary biological evaluation of [H-3]-1-[(S)-N,O-bis-(isoquinolinesulfonyl)-N-methyl-tyrosyl]-4-(o-tolyl )-piperazine, a potent antagonist radioligand for the P2X(7) receptor 157
Totale 20.589
Categoria #
all - tutte 189.738
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 937
Totale 190.675


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.332 0 0 0 0 0 361 112 472 87 527 459 314
2021/20223.062 116 307 271 154 169 131 143 142 100 238 329 962
2022/20232.979 318 175 74 421 526 456 91 265 388 17 158 90
2023/20241.656 148 197 84 38 110 197 67 360 24 17 43 371
2024/20256.037 119 199 487 240 726 540 165 377 935 683 817 749
2025/202610.358 1.703 979 2.080 2.228 2.421 947 0 0 0 0 0 0
Totale 43.018